Businessweek Archives

Table: A Windfall In The Making


News: Analysis & Commentary: DRUGS

TABLE: A Windfall in the Making

Pharmaceutical makers are seeking an average of 12 months' extra protection

from generic competitors for more than 100 drugs

DRUG MONTHS POTENTIAL EXTRA REVENUES

COMPANY/ OF ADDED BECAUSE OF LACK

USE PROTECTION OF GENERIC ALTERNATIVE

MILLIONS OF DOLLARS

ZANTAC 19 $1,000

Glaxo/ulcers

MEVACOR 19 $448

Merck/

cholesterol-lowering

DIFLUCAN 20 $410

Pfizer/

antifungal agent

PRILOSEC 17 $586

Merck/ulcers

CAPOTEN 6 $101

Bristol-Myers

Squibb/hypertension

DATA: PRIME INSTITUTE, UNIVERSITY OF MINNESOTA


Burger King's Young Buns
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus